NBAT1 and neuroblastoma: Being described as tumour suppressor, NBAT-1 might be among crucial regulatory RNAs and so, the therapy against NBAT-1 and its downstream effectors could be a potential novel therapeutic option for the treatment of HR neuroblastoma [151].